Results 121 to 130 of about 16,668 (262)
ABSTRACT Background The loss of the Y chromosome (LOY) and the extreme down‐regulation of Y chromosome gene expression (EDY) are frequently observed in oral squamous cell carcinoma (OSCC). However, their roles in oral potentially malignant disorders (OPMDs) are unclear.
Rui Han +6 more
wiley +1 more source
I113 Newer Therapeutic Agents for Psoriasis: A Dermatological Perspective [PDF]
Nick J. Reynolds
openalex +1 more source
Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma
ABSTRACT Background The standard‐of‐care for advanced periauricular cutaneous squamous cell carcinoma (pCSCC) is surgery and adjuvant radiation therapy. Neoadjuvant immunotherapy recently demonstrated high pathologic response rates in patients with resectable pCSCC.
David Z. Allen +6 more
wiley +1 more source
Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies. [PDF]
Marino M +8 more
europepmc +1 more source
Oral Naturally Derived Agents as an Adjuvant Photoprotection after Dermatologic Surgery
Premjit Juntongjin, Chavanatda Chanyasak
openalex +2 more sources
Potential Use of Essential Oil Isolated fromCleistocalyx operculatusLeaves as a Topical Dermatological Agent for Treatment of Burn Wound [PDF]
Gia‐Buu Tran +2 more
openalex +1 more source
ABSTRACT Background The association of chloride intracellular channel 2 (CLIC2) with tumors has remained unclear. However, recently, CLIC2 was found to exhibit antitumor properties in some tumors. In this study, we aimed to evaluate the clinical relevance of CLIC2 expression in head and neck squamous cell carcinoma (HNSCC) to determine whether it ...
Yuki Hosokawa +9 more
wiley +1 more source
Inclisiran-Induced Fixed Drug Eruption in a Patient With Refractory Hypercholesterolemia. [PDF]
Khan JA, Shahab S.
europepmc +1 more source
POTASSIUM PERMANGANATE AS A CURATIVE AGENT IN DERMATOLOGIC DISEASES
Samuel M. Feldman
openalex +2 more sources
ABSTRACT Background Brain metastases (BM) of differentiated thyroid carcinoma (DTC) are associated with unfavorable prognosis. This study evaluated BM management strategies and patients' outcomes. Methods A retrospective review of patients diagnosed with DTC and BM at Tel Aviv Sourasky and Rabin Medical Centers between 1985 and 2024. Clinical features,
Liyona Kampel +9 more
wiley +1 more source

